Curis (CRIS) Interest & Investment Income (2010 - 2026)
Curis (CRIS) reported Interest & Investment Income of $77000.0 for Q1 2026, down 17.2% on a YoY basis from $93000.0 in Q1 2025, and up 50.98% quarter-over-quarter from $51000.0 in Q4 2025.
Curis (CRIS) Interest & Investment Income (2010 - 2026) Analysis & Trends
Curis has reported Interest & Investment Income for 17 years, with the latest figure at $77000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 17.2% year-over-year to $77000.0; the trailing twelve-month figure through Mar 2026 stood at $300000.0 (down 77.71% YoY), and the FY2025 full-year result was $316000.0, down 82.13% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $77000.0, up from $51000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $815000.0 in Q2 2023, with the low at $51000.0 in Q4 2025.
- Historically, Interest & Investment Income has averaged $365764.7 across 5 years, with a median of $325000.0 in 2024.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 922.64% — and 2025, when it tumbled 86.88%.
- Curis' Interest & Investment Income stood at $542000.0 in 2022, then increased by 22.69% to $665000.0 in 2023, then slumped by 65.86% to $227000.0 in 2024, then plunged by 77.53% to $51000.0 in 2025, then soared by 50.98% to $77000.0 in 2026.
- The last three Interest & Investment Income figures came in at $77000.0 (Q1 2026), $51000.0 (Q4 2025), and $80000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Curis | 8.27 Mn | -6.73 Mn | - | 77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 92,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Sep 30, 2024 | 325,000.00 |
| Jun 30, 2024 | 701,000.00 |
| Mar 31, 2024 | 515,000.00 |
| Dec 31, 2023 | 665,000.00 |
| Sep 30, 2023 | 806,000.00 |
| Jun 30, 2023 | 815,000.00 |
| Mar 31, 2023 | 652,000.00 |
| Dec 31, 2022 | 542,000.00 |
| Sep 30, 2022 | 335,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 80,000.00 |
| Dec 31, 2021 | 53,000.00 |
| Sep 30, 2021 | 54,000.00 |
| Jun 30, 2021 | 58,000.00 |